Skip to content

Hyperion LTK System

by Sunrise Technologies, Inc.

PMA P990078

Active United States

PMA

Valid until

No expiry

PMA approval is not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

PMA P990078↗

FDA record

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA PMA, synced 6 Oct 2026. What this means

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA PMAAPPR Approved NumberP990078 Date30 Jun 2000ApprovedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 6 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA PMA Active

Specification

PMA

Generic Name
Laser, neodymium:Yag, ophthalmic for uses other than posterior capsulotomy & cutting pupillary
PMA Number
FDA Product Code
LOI
Device Class
Class III
Advisory Committee
Ophthalmic
FDA Decision
APPR Approved

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Hyperion LTK System is a laser, neodymium:Yag, ophthalmic device for uses other than posterior capsulotomy & cutting pupillary. It is indicated for the temporary reduction of hyperopia in patients with +0.75 to +2.5 diopters of manifest refraction spherical equivalent at the spectacle plane, with cylinder less than or equal to +-0.75 diopters, who are 40 years of age or older with documented stability of refraction for the prior 6 months.

The device is supplied by Sunrise Technologies, Inc., located in Fremont, CA. It received FDA PMA approval (P990078) on June 30, 2000, and is classified as a Class III device under product code LOI. No information is provided regarding sterility, single-use status, MRI safety, sizes, or storage conditions.

Other devices from Sunrise Technologies, Inc.

See all devices from Sunrise Technologies, Inc. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Hyperion LTK System indicated for?

    The Hyperion LTK System is indicated for the temporary reduction of hyperopia in patients with +0.75 to +2.5 diopters of manifest refraction spherical equivalent at the spectacle plane, with cylinder less than or equal to +-0.75 diopters, who are 40 years of age or older and have demonstrated stability of refraction for the prior 6 months, as defined by a change of less than or equal to 0.50D in spherical and cylindrical components.

  • Who manufactures the Hyperion LTK System and where are they located?

    The Hyperion LTK System is manufactured by Sunrise Technologies, Inc., located at 3400 W. Warren Ave., Fremont, CA 94538.

  • What regulatory authorization does the Hyperion LTK System have?

    The Hyperion LTK System has FDA PMA approval, with PMA number P990078, and was approved on June 30, 2000, following receipt of the application on November 3, 1999.